0102030405
Radiopharmaceuticals in the Multi-Isotope Era | Non-Metal and Metal Isotopes in Molecular Imaging ⚛️
2026-06-12
In the previous post, we discussed how PET imaging is moving beyond F-18 FDG and entering a broader multi-isotope era.
But why are diagnostic isotopes becoming more diversified?
One key reason is that different isotopes have different physical properties and labeling chemistries, making them suitable for different molecules and application scenarios.
🧪 Diagnostic isotopes can be viewed through two major technical routes.
The first route is represented by non-metal isotopes, such as F-18 and C-11.
These isotopes are usually introduced into organic molecules through covalent bonds, helping preserve the original chemical structure and biological behavior of the tracer. This makes them valuable for small-molecule tracers, metabolic imaging, neuroimaging, and drug development.
F-18 FDG is the most successful example, while C-11 is useful for developing small-molecule probes that closely resemble natural organic structures.
🔬 The second route is represented by metal isotopes, such as Ga-68, Cu-64, Zr-89, and Sc-44.
These isotopes are commonly labeled through chelator-based coordination chemistry. The chelator acts as a “bridge”: one end binds the metal isotope, while the other connects to a peptide, antibody, or other targeting molecule.
This modular strategy is especially useful for labeling peptides, antibodies, and targeted molecular probes.
For example, Ga-68-labeled peptide probes are widely used in targeted imaging for neuroendocrine tumors and prostate cancer. Zr-89, with its longer half-life, is well suited for antibody biodistribution studies and target visualization.
🧬 Non-metal and metal isotopes are not replacements for each other. They are complementary tools.
Non-metal isotopes are strong in small molecules, metabolism, and neuroimaging. Metal isotopes offer greater flexibility for peptides, antibodies, targeted probes, and theranostic evaluation.
Together, they expand the molecular imaging toolbox for different diseases, targets, molecules, and clinical questions.
⚛️ This is why multi-isotope production capability matters. Based on medical cyclotron platforms and liquid, gas, and solid target systems, LBT supports both classic non-metal isotopes such as F-18 and C-11, and metal isotopes such as Ga-68, Cu-64, Zr-89, and Sc-44 — providing flexible upstream support for molecular imaging research and clinical translation.










